Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3123PDF: 1203HTML: 140 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1504PDF: 1026HTML: 1694Figure 1: 238 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1435PDF: 1211PDF: 981HTML: 274 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4269PDF: 1259HTML: 2140Fig.1: 252Fig. 2: 151Table 1: 262Table2: 287Table 3: 280 -
-
LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE
1504PDF: 998HTML: 1312fig 1A: 253figure1B: 214 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
4030PDF: 1706HTML: 3956Letter to Editor: 255 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2745PDF: 1276HTML: 180 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
2533PDF: 681HTML: 393 -
Anemia in the elderly: not always what it seems.
3476PDF: 1189HTML: 1828Figure 1: 266Figure 1 revised: 313 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1344PDF: 598HTML: 1729Figures: 223Fifures Sanz: 234tables Sanz: 236Untitled: 229 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
810PDF: 516HTML: 6298 -
COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis
1026PDF: 1332HTML: 167 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1692PDF: 875HTML: 1552Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 240 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1730PDF: 894HTML: 2222Untitled: 288Untitled: 256Untitled: 246Untitled: 278Untitled: 273 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
5025PDF: 1653HTML: 2291Untitled: 289Untitled: 310Untitled: 330Untitled: 284Untitled: 294 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2277PDF: 1410HTML: 3531 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
1042PDF: 784HTML: 391 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1995PDF: 830HTML: 600 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
3122PDF: 1550HTML: 337 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3482PDF: 1382HTML: 2380 -
BONE MARROW ABONRMALITIES IN HIV INFECTION
2076PDF: 1235HTML: 1807 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1795PDF: 834HTML: 1526 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2969PDF: 1065HTML: 4762







